Repositioned to kill stem cells

Tessa Holyoake () and David Vetrie ()
Additional contact information
Tessa Holyoake: Tessa Holyoake and David Vetrie are at the Institute of Cancer Sciences, University of Glasgow, Glasgow G12 0ZD (T.H.) and Glasgow G61 1QH (D.V.), UK.
David Vetrie: Tessa Holyoake and David Vetrie are at the Institute of Cancer Sciences, University of Glasgow, Glasgow G12 0ZD (T.H.) and Glasgow G61 1QH (D.V.), UK.

Nature, 2015, vol. 525, issue 7569, 328-329

Abstract: Chemotherapy-resistant cancer stem cells make it hard to cure many forms of the disease. Repositioning an existing drug to tackle this problem could significantly improve treatment for one form of leukaemia. See Letter p.380

Date: 2015
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/nature15213 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:525:y:2015:i:7569:d:10.1038_nature15213

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature15213

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().